AVEO Pharmaceuticals Granted Patent For Unique Genetic Screen To Identify Novel Cancer Drug Targets
                   
medicalnewstoday.com     May 26, 2008            

AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, tannounced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. Patent No. [read full story]                    


View all news articles about*:
Ambulatory AVEO Biology Biopharmaceuticals Cancer Cancers Care Corporate Discoveries Eli Health Industrial Intellectual Issues Legal Lilly Medical Medicines Oncology OSI Patents Pharmaceuticals Pipeline Property Remedies Research Schering Scientific Therapy Transport Transportation
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Eli Lilly acquires SGX Pharmaceuticals

pharmaceutical-business-review.com     33 mins ago   1 related          

Eli Lilly and Company has acquired SGX Pharmaceuticals, a San Diego-based biotechnology company focused on drug discovery and development in the area of oncology. Under the merger agreement, Lilly will acquire all of the...                    

comments

                   

“Scent” May Aid in Skin Cancer Diagnosis

cancerconsultants.com     9 hrs ago          

The concentration of certain molecules called volatile organic compounds (VOCs) given off by a cancer may ultimately contribute to accurate diagnosis of skin cancer. These results were recently presented at the 2008 annual...                    

comments

COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis.

biowizard.com     10 hrs ago          

Authors' Affiliations: State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University. PURPOSE: X protein (HBx), a product of hepatitis B virus, has been closely associated with the development of...                    

comments

                   

The Oncology Group Announces the 11th Edition of Its Popular Handbook, CANCER MANAGEMENT: A...

prnewswire.com     11 hrs ago          

The Oncology Group Announces the 11th Edition of Its Popular Handbook, CANCER MANAGEMENT: A MULTIDISCIPLINARY APPROACH MANHASSET, N.Y., Aug. 21 /PRNewswire/ -- The Oncology Group is pleased to announce the publication of the...                    

comments